Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα

US9540333B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Joseph B. Santella · Springfield, US
• Ryan M. Moslin · Princeton, US
• David S. Weinstein · Plainsboro, US
• Stephen T. Wrobleski · Whitehouse Station, US
• John S. Tokarski · Princeton, US

Key dates

• Filing date: Nov 7, 2013
• Grant date: Jan 10, 2017
• Expiry date: Nov 7, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D239/95
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds having the following formula (I): or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα by acting on Tyk-2 to cause signal transduction inhibition.